Mr. John D'Antonio

John D'Antonio is the Founder and Principal of Pharma Consultants International, Inc., and Managing Partner of Trigeminis Integrated Business Development.PCI is a diversified Business Development, Licensing, Acquisitions and Marketing Services Firm that provides highly specialized information resources, management consulting and transaction expertise in the pharmaceutical, biotech, and health care industry sectors.PCI concentrates on addressing the strategic growth requirements of its clients emphasizing innovation in formulations, delivery systems and bioinformatics.Mr. D'Antonio has successfully co-invented and licensed several of his own patented systems in the transdermal, and implantable delivery.Mr. D'Antonio has worked in the field of drug delivery and pharmaceutical polymers for more than 20 years.His experience in drug delivery systems includes business development, sales, marketing of cutting edge technology, product launches, licensing and acquisitions, joint ventures, emerging growth company private and public financing, strategic planning, and the integration of medical, scientific and business issues from discovery to market.Mr. D'Antonio's firm provides solutions that structure business disciplines to facilitate quick and data based decisions and ensure accountability for execution in a changing environment.

John D'Antonio is the Founder and Principal of Pharma Consultants International, Inc., and Managing Partner of Trigeminis Integrated Business Development.PCI is a diversified Business Development, Licensing, Acquisitions and Marketing Services Firm that provides highly specialized information resources, management consulting and transaction expertise in the pharmaceutical, biotech, and health care industry sectors.PCI concentrates on addressing the strategic growth requirements of its clients emphasizing innovation in formulations, delivery systems and bioinformatics.Mr. D'Antonio has successfully co-invented and licensed several of his own patented systems in the transdermal, and implantable delivery.Mr. D'Antonio has worked in the field of drug delivery and pharmaceutical polymers for more than 20 years.His experience in drug delivery systems includes business development, sales, marketing of cutting edge technology, product launches, licensing and acquisitions, joint ventures, emerging growth company private and public financing, strategic planning, and the integration of medical, scientific and business issues from discovery to market.Mr. D'Antonio's firm provides solutions that structure business disciplines to facilitate quick and data based decisions and ensure accountability for execution in a changing environment.

ou never know how a horse actually feels before a race,particularly the one you've just bet on.He, or she for that matter, could have a headache, the flu, a cold, or basically not even be motivated to race at all.Maybe all he wants to do is just hang out in the shed with the ladies and eat.

John D'Antonio is the Founder & Principal of Pharma Consultants International, Inc., (PCI), based in Princeton, NJ. PCI is a diversified Business Development, Licensing, Acquisitions, and Marketing Services Firm that provides highly specialized information resources, management consulting, and transaction expertise in the pharmaceutical, biotech, and healthcare industries.Mr. D'Antonio has successfully co-invented and licensed several of his own patented transdermal and implantable delivery systems.He has worked in the field of drug delivery and pharmaceutical polymers for more than 15 years.His experience in drug delivery systems includes business development; sales; marketing of cutting-edge technology; product launches; licensing and acquisitions; joint ventures; private and public financing; strategic planning; and the integration of medical, scientific, and business issues from discovery to market.Mr. D'Antonio's firm provides solutions that structure business disciplines to facilitate quick and data-based decisions and ensure accountability for execution in a changing environment.

Advisory Board member John D'Antonio commented, "Participating on the board will certainly expand the opportunity for all of us to share valuable insights gained from managing research and licensing collaborations with new technologies, products and services, from both the small and large company perspectives."
...
-- John D'Antonio, Founder and Principal, Pharma Consultants International, Inc., Partner of Trigeminis, LLC

By: John D'Antonio
...
John D'Antonio is the Founder and Principal of Pharma Consultants International, Inc., and Managing Partner of Trigeminis Integrated Business Development.PCI is a diversified Business Development, Licensing, Acquisitions and Marketing Services Firm that provides highly specialized information resources, management consulting and transaction expertise in the pharmaceutical, biotech, and health care industry sectors.PCI concentrates on addressing the strategic growth requirements of its clients emphasizing innovation in formulations, delivery systems and bioinformatics.Mr. D'Antonio has successfully co-invented and licensed several of his own patented systems in the transdermal, and implantable delivery.Mr. D'Antonio has worked in the field of drug delivery and pharmaceutical polymers for more than 20 years.His experience in drug delivery systems includes business development, sales, marketing of cutting edge technology, product launches, licensing and acquisitions, joint ventures, emerging growth company private and public financing, strategic planning, and the integration of medical, scientific and business issues from discovery to market.Mr. D'Antonio's firm provides solutions that structure business disciplines to facilitate quick and data based decisions and ensure accountability for execution in a changing environment.

Search the Articles:

By: John D'Antonio
...
John D'Antonio is the Founder and Principal of Pharma Consultants International, Inc., and Managing Partner of Trigeminis Integrated Business Development.PCI is a diversified Business Development, Licensing, Acquisitions and Marketing Services Firm that provides highly specialized information resources, management consulting and transaction expertise in the pharmaceutical, biotech, and health care industry sectors.PCI concentrates on addressing the strategic growth requirements of its clients emphasizing innovation in formulations, delivery systems and bioinformatics.Mr. D'Antonio has successfully co-invented and licensed several of his own patented systems in the transdermal, and implantable delivery.Mr. D'Antonio has worked in the field of drug delivery and pharmaceutical polymers for more than 20 years.His experience in drug delivery systems includes business development, sales, marketing of cutting edge technology, product launches, licensing and acquisitions, joint ventures, emerging growth company private and public financing, strategic planning, and the integration of medical, scientific and business issues from discovery to market.Mr. D'Antonio's firm provides solutions that structure business disciplines to facilitate quick and data based decisions and ensure accountability for execution in a changing environment.

By: John D'Antonio
...
John D'Antonio is the Founder & Principal of Pharma Consultants International, Inc., (PCI), based in Princeton, NJ. PCI is a diversified Business Development, Licensing, Acquisitions, and Marketing Services Firm that provides highly specialized information resources, management consulting, and transaction expertise in the pharmaceutical, biotech, and healthcare industries.Mr. D'Antonio has successfully co-invented and licensed several of his own patented transdermal and implantable delivery systems.He has worked in the field of drug delivery and pharmaceutical polymers for more than 15 years.His experience in drug delivery systems includes business development; sales; marketing of cutting-edge technology; product launches; licensing and acquisitions; joint ventures; private and public financing; strategic planning; and the integration of medical, scientific, and business issues from discovery to market.Mr. D'Antonio's firm provides solutions that structure business disciplines to facilitate quick and data-based decisions and ensure accountability for execution in a changing environment.

Moderator: John D'Antonio, President and CEO, PCI, Inc.

John D'Antonio, Founder and Principal, Pharma Consultants International, Inc.
...
John D'Antonio, Founder and Principal, Pharma Consultants International, Inc.

John D'Antonio is the Founder and Principal of Pharma Consultants International, Inc., (PCI) based in Princeton, NJ. PCI is a diversified Business Development, Licensing, Acquisitions and Marketing Services Firm that provides highly specialized information resources, management consulting and transaction expertise in the pharmaceutical, biotech, and health care industry sectors.PCI concentrates on addressing the strategic growth requirements of its clients emphasizing innovation in formulations, delivery systems and bioinformatics.Mr. D'Antonio is also a Partner of Trigeminis, LLC.Mr. D'Antonio has successfully co-invented and licensed several of his own patented systems in the transdermal, and implantable delivery.Mr. D'Antonio has worked in the field of drug delivery and pharmaceutical polymers than 15 years.His experience in drug delivery systems includes business development, sales, marketing of cutting edge technology, product launches, licensing and acquisitions, joint ventures, emerging growth company private and public financing, strategic planning, and the integration of medical, scientific and business issues from discovery to market.

By: John D'Antonio
...
John D'Antonio is the Founder & Principal of Pharma Consultants International, Inc., (PCI), based in Princeton, NJ. PCI is a diversified Business Development, Licensing, Acquisitions, and Marketing Services Firm that provides highly specialized information resources, management consulting, and transaction expertise in the pharmaceutical, biotech, and healthcare industries.Mr. D'Antonio has successfully co-invented and licensed several of his own patented transdermal and implantable delivery systems.He has worked in the field of drug delivery and pharmaceutical polymers for more than 15 years.His experience in drug delivery systems includes business development; sales; marketing of cutting-edge technology; product launches; licensing and acquisitions; joint ventures; private and public financing; strategic planning; and the integration of medical, scientific, and business issues from discovery to market.